-
Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations
Authors:
Fábio Carneiro,
Dario Saracino,
Vincent Huin,
Fabienne Clot,
Cécile Delorme,
Aurélie Méneret,
Stéphane Thobois,
Florence Cormier,
Jean Christophe Corvol,
Timothée Lenglet,
Marie Vidailhet,
Marie-Odile Habert,
Audrey Gabelle,
Émilie Beaufils,
Karl Mondon,
Mélissa Tir,
Daniela Andriuta,
Alexis Brice,
Vincent Deramecourt,
Isabelle Le Ber
Abstract:
Introduction: A phenotype of isolated parkinsonism mimicking Idiopathic Parkinson's Disease (IPD) is a rare clinical presentation of GRN and C9orf72 mutations, the major genetic causes of frontotemporal dementia (FTD). It still remains controversial if this association is fortuitous or not, and which clinical clues could reliably suggest a genetic FTD etiology in IPD patients. This study aims to d…
▽ More
Introduction: A phenotype of isolated parkinsonism mimicking Idiopathic Parkinson's Disease (IPD) is a rare clinical presentation of GRN and C9orf72 mutations, the major genetic causes of frontotemporal dementia (FTD). It still remains controversial if this association is fortuitous or not, and which clinical clues could reliably suggest a genetic FTD etiology in IPD patients. This study aims to describe the clinical characteristics of FTD mutation carriers presenting with IPD phenotype, provide neuropathological evidence of the mutation's causality, and specifically address their "red flags" according to current IPD criteria. Methods: Seven GRN and C9orf72 carriers with isolated parkinsonism at onset, and three patients from the literature were included in this study. To allow better delineation of their phenotype, the presence of supportive, exclusion and "red flag" features from MDS criteria were analyzed for each case. Results: Amongst the ten patients (5 GRN, 5 C9orf72), seven fulfilled probable IPD criteria during all the disease course, while behavioral/language or motoneuron dysfunctions occurred later in three. Disease duration was longer and dopa-responsiveness was more sustained in C9orf72 than in GRN carriers. Subtle motor features, cognitive/behavioral changes, family history of dementia/ALS were suggestive clues for a genetic diagnosis. Importantly, neuropathological examination in one patient revealed typical TDP-43-inclusions without alpha-synucleinopathy, thus demonstrating the causal link between FTD mutations, TDP-43-pathology and PD phenotype. Conclusion: We showed that, altogether, family history of early-onset dementia/ALS, the presence of cognitive/behavioral dysfunction and subtle motor characteristics are atypical features frequently present in the parkinsonian presentations of GRN and C9orf72 mutations .
△ Less
Submitted 24 January, 2022;
originally announced January 2022.
-
Clinica: an open source software platform for reproducible clinical neuroscience studies
Authors:
Alexandre Routier,
Ninon Burgos,
Mauricio Díaz,
Michael Bacci,
Simona Bottani,
Omar El-Rifai,
Sabrina Fontanella,
Pietro Gori,
Jérémy Guillon,
Alexis Guyot,
Ravi Hassanaly,
Thomas Jacquemont,
Pascal Lu,
Arnaud Marcoux,
Tristan Moreau,
Jorge Samper-González,
Marc Teichmann,
Elina Thibeau--Sutre,
Ghislain Vaillant,
Junhao Wen,
Adam Wild,
Marie-Odile Habert,
Stanley Durrleman,
Olivier Colliot
Abstract:
We present Clinica (www.clinica.run), an open-source software platform designed to make clinical neuroscience studies easier and more reproducible. Clinica aims for researchers to i) spend less time on data management and processing, ii) perform reproducible evaluations of their methods, and iii) easily share data and results within their institution and with external collaborators. The core of Cl…
▽ More
We present Clinica (www.clinica.run), an open-source software platform designed to make clinical neuroscience studies easier and more reproducible. Clinica aims for researchers to i) spend less time on data management and processing, ii) perform reproducible evaluations of their methods, and iii) easily share data and results within their institution and with external collaborators. The core of Clinica is a set of automatic pipelines for processing and analysis of multimodal neuroimaging data (currently, T1-weighted MRI, diffusion MRI and PET data), as well as tools for statistics, machine learning and deep learning. It relies on the brain imaging data structure (BIDS) for the organization of raw neuroimaging datasets and on established tools written by the community to build its pipelines. It also provides converters of public neuroimaging datasets to BIDS (currently ADNI, AIBL, OASIS and NIFD). Processed data include image-valued scalar fields (e.g. tissue probability maps), meshes, surface-based scalar fields (e.g. cortical thickness maps) or scalar outputs (e.g. regional averages). These data follow the ClinicA Processed Structure (CAPS) format which shares the same philosophy as BIDS. Consistent organization of raw and processed neuroimaging files facilitates the execution of single pipelines and of sequences of pipelines, as well as the integration of processed data into statistics or machine learning frameworks. The target audience of Clinica is neuroscientists or clinicians conducting clinical neuroscience studies involving multimodal imaging, and researchers developing advanced machine learning algorithms applied to neuroimaging data.
△ Less
Submitted 21 July, 2021;
originally announced July 2021.
-
Neural correlates of episodic memory in the Memento cohort
Authors:
Stéphane Epelbaum,
Vincent Bouteloup,
Jean Mangin,
Valentina La Corte,
Raffaela Migliaccio,
Hugo Bertin,
Marie O. Habert,
Clara Fischer,
Chabha Azouani,
Ludovic Fillon,
Marie Chupin,
Bruno Vellas,
Florence Pasquier,
Jean Dartigues,
Frédéric Blanc,
Audrey Gabelle,
Mathieu Ceccaldi,
Pierre Krolak-Salmon,
Jacques Hugon,
Olivier Hanon,
Olivier Rouaud,
Renaud David,
Geneviève Chêne,
Bruno Dubois,
Carole Dufouil
Abstract:
IntroductionThe free and cued selective reminding test is used to identify memory deficits in mild cognitive impairment and demented patients. It allows assessing three processes: encoding, storage, and recollection of verbal episodic memory.MethodsWe investigated the neural correlates of these three memory processes in a large cohort study. The Memento cohort enrolled 2323 outpatients presenting…
▽ More
IntroductionThe free and cued selective reminding test is used to identify memory deficits in mild cognitive impairment and demented patients. It allows assessing three processes: encoding, storage, and recollection of verbal episodic memory.MethodsWe investigated the neural correlates of these three memory processes in a large cohort study. The Memento cohort enrolled 2323 outpatients presenting either with subjective cognitive decline or mild cognitive impairment who underwent cognitive, structural MRI and, for a subset, fluorodeoxyglucose--positron emission tomography evaluations.ResultsEncoding was associated with a network including parietal and temporal cortices; storage was mainly associated with entorhinal and parahippocampal regions, bilaterally; retrieval was associated with a widespread network encompassing frontal regions.DiscussionThe neural correlates of episodic memory processes can be assessed in large and standardized cohorts of patients at risk for Alzheimer's disease. Their relation to pathophysiological markers of Alzheimer's disease remains to be studied.
△ Less
Submitted 19 December, 2018;
originally announced December 2018.
-
COGEVIS: A New Scale to Evaluate Cognition in Patients with Visual Deficiency
Authors:
Claire Meyniel,
Dalila Samri,
Farah Stefano,
Joel Crevoisier,
Florence Bonté,
Raffaella Migliaccio,
Laure Delaby,
Anne Bertrand,
Marie Odile Habert,
Bruno Dubois,
Bahram Bodaghi,
Stéphane Epelbaum
Abstract:
We evaluated the cognitive status of visually impaired patients referred to low vision rehabilitation (LVR) based on a standard cognitive battery and a new evaluation tool, named the COGEVIS, which can be used to assess patients with severe visual deficits. We studied patients aged 60 and above, referred to the LVR Hospital in Paris. Neurological and cognitive evaluations were performed in an expe…
▽ More
We evaluated the cognitive status of visually impaired patients referred to low vision rehabilitation (LVR) based on a standard cognitive battery and a new evaluation tool, named the COGEVIS, which can be used to assess patients with severe visual deficits. We studied patients aged 60 and above, referred to the LVR Hospital in Paris. Neurological and cognitive evaluations were performed in an expert memory center. Thirty-eight individuals, 17 women and 21 men with a mean age of 70.3 $\pm$ 1.3 years and a mean visual acuity of 0.12 $\pm$ 0.02, were recruited over a one-year period. Sixty-three percent of participants had normal cognitive status. Cognitive impairment was diagnosed in 37.5% of participants. The COGEVIS score cutoff point to screen for cognitive impairment was 24 (maximum score of 30) with a sensitivity of 66.7% and a specificity of 95%. Evaluation following 4 months of visual rehabilitation showed an improvement of Instrumental Activities of Daily Living (p = 0 004), National Eye Institute Visual Functioning Questionnaire (p = 0 035), and Montgomery-Åsberg Depression Rating Scale (p = 0 037). This study introduces a new short test to screen for cognitive impairment in visually impaired patients.
△ Less
Submitted 18 December, 2018;
originally announced December 2018.
-
Yet Another ADNI Machine Learning Paper? Paving The Way Towards Fully-reproducible Research on Classification of Alzheimer's Disease
Authors:
Jorge Samper-González,
Ninon Burgos,
Sabrina Fontanella,
Hugo Bertin,
Marie-Odile Habert,
Stanley Durrleman,
Theodoros Evgeniou,
Olivier Colliot
Abstract:
In recent years, the number of papers on Alzheimer's disease classification has increased dramatically, generating interesting methodological ideas on the use machine learning and feature extraction methods. However, practical impact is much more limited and, eventually, one could not tell which of these approaches are the most efficient. While over 90\% of these works make use of ADNI an objectiv…
▽ More
In recent years, the number of papers on Alzheimer's disease classification has increased dramatically, generating interesting methodological ideas on the use machine learning and feature extraction methods. However, practical impact is much more limited and, eventually, one could not tell which of these approaches are the most efficient. While over 90\% of these works make use of ADNI an objective comparison between approaches is impossible due to variations in the subjects included, image pre-processing, performance metrics and cross-validation procedures. In this paper, we propose a framework for reproducible classification experiments using multimodal MRI and PET data from ADNI. The core components are: 1) code to automatically convert the full ADNI database into BIDS format; 2) a modular architecture based on Nipype in order to easily plug-in different classification and feature extraction tools; 3) feature extraction pipelines for MRI and PET data; 4) baseline classification approaches for unimodal and multimodal features. This provides a flexible framework for benchmarking different feature extraction and classification tools in a reproducible manner. We demonstrate its use on all (1519) baseline T1 MR images and all (1102) baseline FDG PET images from ADNI 1, GO and 2 with SPM-based feature extraction pipelines and three different classification techniques (linear SVM, anatomically regularized SVM and multiple kernel learning SVM). The highest accuracies achieved were: 91% for AD vs CN, 83% for MCIc vs CN, 75% for MCIc vs MCInc, 94% for AD-A$β$+ vs CN-A$β$- and 72% for MCIc-A$β$+ vs MCInc-A$β$+. The code is publicly available at https://gitlab.icm-institute.org/aramislab/AD-ML (depends on the Clinica software platform, publicly available at http://www.clinica.run).
△ Less
Submitted 21 September, 2017;
originally announced September 2017.
